TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EXEL

Exelixis Inc

Healthcare · Biotechnology

58.40$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Exelixis Inc (EXEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 884 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EXEL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-235 -142 206 166 416 527 209 401 363 333 700 884
2.4 1.4 1.0 1.2 7.8 8.3 9.1 14 21 26 29 29
10 22 23 24 44 57 105 120 108 106 94 113
11 28 40 17 -206 128 123 195 154
-10 -26 227 -6.9 -80 67 -40 -39 -13 -14 -13 -191
0.5 0.4 1.7 21 33 13 30 64 138 163 66 40
146 50 -216 36 -298 -587 -131 -43 -524 -27 -117 350
0.0 0.0 0.0 0.0
77 -0.5 -4.1 -6.6 -7.6 -9.9 -50 -39 24 -550 -652 -948
-12 -4.4 -0.6 -186 0.0
65 153 20 -170 9.7 13 -25 -15 0.6 -546 -629 -970
-24 61 10 31 128 -48 53 343 -161 -240 -46 265
-236 -142 205 144 382 514 179 337 224 170 634 844

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?